AAAAAA

   
Results: 1-9 |
Results: 9
A 65 KDA ONCOFETAL PROTEIN (P65), PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND KI67 EXPRESSION IN BREAST-CANCER PATIENTS
Authors: NIEWIADOMSKA H MIROWSKI M STEMPIEN M OLBORSKI B BLONSKI JZ HANAUSEK M WIERZBICKI R
Citation: H. Niewiadomska et al., A 65 KDA ONCOFETAL PROTEIN (P65), PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND KI67 EXPRESSION IN BREAST-CANCER PATIENTS, Neoplasma, 45(4), 1998, pp. 216-222
EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND P53, BCL-2 OR C-ERB B-2 PROTEINS ON REED-STERNBERG CELLS - PROGNOSTIC-SIGNIFICANCE IN HODGKINS-DISEASE
Authors: SMOLEWSKI P NIEWIADOMSKA H BLONSKI JZ ROBAK T KRYKOWSKI E
Citation: P. Smolewski et al., EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND P53, BCL-2 OR C-ERB B-2 PROTEINS ON REED-STERNBERG CELLS - PROGNOSTIC-SIGNIFICANCE IN HODGKINS-DISEASE, Neoplasma, 45(3), 1998, pp. 140-147
PRETREATMENT IMMUNOHISTOCHEMICAL PATTERN OF REED-STERNBERG AND HODGKINS CELLS IN RESPONDING AND NON-RESPONDING PATIENTS WITH HODGKINS-DISEASE - CELLULAR EXPRESSION OF ONCOPROTEINS INVOLVED IN APOPTOSIS REGULATION
Authors: SMOLEWSKI P NIEWIADOMSKA H BLONSKI JZ ROBAK T
Citation: P. Smolewski et al., PRETREATMENT IMMUNOHISTOCHEMICAL PATTERN OF REED-STERNBERG AND HODGKINS CELLS IN RESPONDING AND NON-RESPONDING PATIENTS WITH HODGKINS-DISEASE - CELLULAR EXPRESSION OF ONCOPROTEINS INVOLVED IN APOPTOSIS REGULATION, British Journal of Haematology, 102(1), 1998, pp. 117-117
NUCLEAR-PROTEIN P44 - POTENTIAL MARKER OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BLONSKI JZ CHRUCCIEL J NIEWIADOMSKA H SZYMCZYK P ROBAK T KILIANSKA ZM
Citation: Jz. Blonski et al., NUCLEAR-PROTEIN P44 - POTENTIAL MARKER OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 127-127
CORRELATION OF SEVERAL CYTOKINES AND THEIR SOLUBLE RECEPTORS WITH CLINICAL, HEMATOLOGICAL AND IMMUNOLOGICAL PARAMETERS IN UNTREATED PATIENTS WITH B-CELL LYMPHOCYTIC-LEUKEMIA
Authors: BLASINSKAMORAWIEC M BLONSKI JZ ROBAK T
Citation: M. Blasinskamorawiec et al., CORRELATION OF SEVERAL CYTOKINES AND THEIR SOLUBLE RECEPTORS WITH CLINICAL, HEMATOLOGICAL AND IMMUNOLOGICAL PARAMETERS IN UNTREATED PATIENTS WITH B-CELL LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 128-128
IMMUNOHISTOCHEMICAL STUDY OF 65-KDA ONCOFETAL PROTEIN EXPRESSION IN BREAST-CANCER
Authors: MIROWSKI M BLONSKI JZ NIEWIADOMSKA H OLBORSKI B WALASZEK Z HANAUSEK M WOZNIAK L
Citation: M. Mirowski et al., IMMUNOHISTOCHEMICAL STUDY OF 65-KDA ONCOFETAL PROTEIN EXPRESSION IN BREAST-CANCER, Breast, 6(5), 1997, pp. 284-290
THE EFFECT OF 2-H INFUSION OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) WITH PREDNISONE IN PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: ROBAK T BLASINSKAMORAWIEC M BLONSKI JZ KRYKOWSKI E KOMARNICKI M TREPINSKA E KAZMIERCZUK M HANSZ J DMOSZYNSKA A ROLINSKI J KONOPKA L SKOTNICKI AB NOWAK WS KOTLAREKHAUS S ZDZIARSKA B URASINSKI I
Citation: T. Robak et al., THE EFFECT OF 2-H INFUSION OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) WITH PREDNISONE IN PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of cancer, 33(14), 1997, pp. 2347-2351
2-CHLORODEOXYADENOSINE (2-CDA) AND PREDNISONE(P) VERSUS CHLORAMBUCIL (CHL) AND PREDNISONE AS A FIRST LINE THERAPY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: ROBAK T BLASINSKAMORAWIEC M BLONSKI JZ KRYKOWSKI E DMOSZYNSKA A SKOTNICKI AB KONOPKA L HELLMANN A KURATOWSKA Z URASINSKI I KOTLAREKHAUS S MAJ S
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) AND PREDNISONE(P) VERSUS CHLORAMBUCIL (CHL) AND PREDNISONE AS A FIRST LINE THERAPY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2361-2361
EXPRESSION OF AN ONCOFETAL 65-KDA PHOSPHOPROTEIN IN LYMPHOCYTIC AND GRANULOCYTIC LEUKEMIAS
Authors: HANAUSEK M WANG SXC BLONSKI JZ KULESZA EP WALASZEK Z MIROWSKI M
Citation: M. Hanausek et al., EXPRESSION OF AN ONCOFETAL 65-KDA PHOSPHOPROTEIN IN LYMPHOCYTIC AND GRANULOCYTIC LEUKEMIAS, International journal of hematology, 63(3), 1996, pp. 193-203
Risultati: 1-9 |